Drug Detail

Information about PDR001

Generic Name
IND
PDR001
Brand Name (US)
Manufacturer
Novartis
Drug Type
Delivery
Intravenous
Approval Status
Indications
Overall Strategy
Immune system
Strategy
Stimulate the immune system
Drug Category
PD-1 Inhibitor


Links

 

Novartis R&D page
   

Trials of this drug

  

Phase I/II Study of PDR001 in Patients With Advanced Malignancies
   

Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed